151 – 160 of 320
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Brain repair and reprogramming : the route to clinical translation
Grealish, S. LU ; Drouin-Ouellet, J. LU and Parmar, M. LU
(2016)
In Journal of Internal Medicine
280(3).
p.265-275
- Contribution to journal › Scientific review
-
Mark
The association between indicators of health and housing in people with Parkinson's disease
Nilsson, Maria H. LU
; Ullén, Susann
; Ekström, Henrik
LU
and Iwarsson, Susanne
LU
(2016)
In BMC Geriatrics
16(1).
- Contribution to journal › Article
-
Mark
Platelet-derived growth factor-BB has neurorestorative effects and modulates the pericyte response in a partial 6-hydroxydopamine lesion mouse model of Parkinson's disease
Padel, Thomas LU ; Ozen, Ilknur LU ; Boix, Jordi LU ; Barbariga, Marco LU ; Gaceb, Abderahim LU ; Roth, Michaela LU and Paul, Gesine LU
(2016)
In Neurobiology of Disease
94.
p.95-105
- Contribution to journal › Article
-
Mark
Chemical properties of lipids strongly affect the kinetics of the membrane-induced aggregation of α-synuclein
(2016) In Proceedings of the National Academy of Sciences of the United States of America 113(26). p.7065-7070
- Contribution to journal › Article
-
Mark
Validation of an improved scale for rating L-DOPA-induced dyskinesia in the mouse and effects of specific dopamine receptor antagonists
Sebastianutto, Irene LU ; Maslava, Natallia LU ; Hopkins, Corey R. and Cenci Nilsson, Angela LU
(2016)
In Neurobiology of Disease
96.
p.156-170
- Contribution to journal › Article
-
Mark
Dissociation of metabolic and hemodynamic levodopa responses in the 6-hydroxydopamine rat model
Lerner, Renata P. ; Bimpisidis, Zisis LU ; Agorastos, Stergiani ; Scherrer, Sandra ; Dewey, Stephen L. ; Cenci Nilsson, Angela LU
and Eidelberg, David
(2016)
In Neurobiology of Disease
96.
p.31-37
- Contribution to journal › Article
-
Mark
Pathogenic effects of alpha-synuclein: modifications and toxicity
(2016)
- Thesis › Doctoral thesis (compilation)
-
Mark
How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson's disease?
Volpicelli-Daley, Laura A ; Kirik, Deniz LU
; Stoyka, Lindsay E
; Standaert, David G
and Harms, Ashley S
(2016)
In Journal of Neurochemistry
139(S1).
p.131-155
- Contribution to journal › Scientific review
-
Mark
Duration of disease does not equally influence all aspects of quality of life in Parkinson's disease
Benge, Jared F. ; Kekecs, Zoltán LU
; Encarnacion, Elmyra
; Ainslie, Melissa
; Herff, Christina
; Elkins, Gary
and Herath, Priyantha
(2016)
In Journal of Clinical Neuroscience
28.
p.102-106
- Contribution to journal › Article
-
Mark
Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosis
Parnetti, Lucilla ; Cicognola, Claudia LU
; Eusebi, Paolo
and Chiasserini, Davide
(2016)
In Biomarkers in Medicine
10(1).
p.35-49
- Contribution to journal › Scientific review